Purpose and goal
Sepsis is the leading cause of death in hospitals and affects 3.4 million annually
people in the EU and 1.7 million in the US. Although sepsis can rapidly progress from symptoms to death within a day, current diagnostic methods take several days to identify
the pathogen and its antibiotic susceptibility. The aim of this project is to develop a macro-to-micro solution (FAST) that isolates bacteria from blood within 30 minutes for rapid diagnostics.
Expected effects and result
Through the deeptech project, we will develop the first prototype of our FAST solution and carry out tests in a laboratory environment to ensure its functionality and performance. The goal is to collect the necessary data and create an evidence base that supports that the solution meets the requirements according to the IVDR (In Vitro Diagnostic Regulation). This is an important step towards ensuring that the solution is ready for further development and future use in healthcare.
Planned approach and implementation
The project is carried out in five steps: 1) Extend lab tests with commercially relevant performance metrics (M1-M4). 2) Develop a manual workflow to simulate function (M2-M6). 3) Create a prototype with partially automated components, including MEMS filters and optical reading platform ( M1-M10). 4) Present results to experts and collect feedback (M3-M12). 5) Analyze production costs for different volumes (M11-M12).
The project description has been provided by the project members themselves and the text has not been looked at by our editors.
